Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Lung Cancer × aflutinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non Small Cell Lung Cancer NSCLC 1 Neoplasm, Residual 1 NSCLC 1 Advanced Lung Cancer 1 Adenocarcinoma of Lung 1

Interventions

Injections 3 toripalimab 2 Carboplatin 2 aflutinib 1 Pemetrexed 1 Paclitaxel 1 Etoposide 1 Docetaxel 1 Cisplatin 1 Chlorogenic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07229599 2025-11-17

A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2 Recruiting

Advanced Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡